Vimarsana
Biggest News Aggregation in the World

Target Conference News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Target Conference. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Target Conference Today - Breaking & Trending Today

SK Biopharmaceuticals' Proteovant Therapeutics Presents Preclinical Data on IKZF2 Protein Degrader Program and MOPED™ Molecular Glue Screening Platform at the 20th Annual Discovery on Target Conference - Vimarsana News

SK Biopharmaceuticals' Proteovant Therapeutics Presents Preclinical Data on IKZF2 Protein Degrader Program and MOPED™ Molecular Glue Screening Platform at the 20th Annual Discovery on Target Conference

Published: September 27, 2023

/PRNewswire/ -- SK Biopharmaceuticals, a global biotech focused on the research, development and commercialization of treatments for disorders of the central...

Source: prnewswire.com
Related Topics:
South KoreaSoult UkpyolsiUnited StatesHyoungrae ChoDonghoon LeeDina AlbaneseCorey StricklandSource Sk Biopharmaceuticals Co LtdMost Influential CompaniesSk Biopharmaceuticals Co LtdSk GroupSk Life Science IncSk IncProteovant TherapeuticsAnnual DiscoveryTarget ConferenceTarget Meeting PresentationsNovel PlatformMolecular GluesMolecular Glue DegraderInfluential CompaniesSk Biopharmaceuticals Co
SK Biopharmaceuticals' Proteovant Therapeutics Presents Preclinical Data on IKZF2 Protein Degrader Program and MOPEDtm Molecular Glue Screening Platform at the 20th Annual Discovery on Target Conference - Vimarsana News

SK Biopharmaceuticals' Proteovant Therapeutics Presents Preclinical Data on IKZF2 Protein Degrader Program and MOPEDtm Molecular Glue Screening Platform at the 20th Annual Discovery on Target Conference

Published: September 27, 2023

SK Biopharmaceuticals, a global biotech focused on the research, development and commercialization of treatments for disorders of the central nervous system (CNS) and oncology, and its U.S. R&D subsidiary, Proteovant Therapeutics, today announced...

Source: lelezard.com
Related Topics:
United StatesSouth KoreaSoult UkpyolsiDonghoon LeeDina AlbaneseCorey StricklandHyoungrae ChoSk GroupSk Life Science IncSource Sk Biopharmaceuticals Co LtdMost Influential CompaniesSk Biopharmaceuticals Co LtdSk IncProtein Degrader ProgramProteovant Therapeutics Presents Preclinical DataDegrader ProgramMolecular Glue Screening PlatformAnnual DiscoveryProteovant TherapeuticsTarget ConferenceTarget Meeting PresentationsNovel PlatformMolecular GluesMolecular Glue DegraderInfluential Companies
Arbutus Reports Third Quarter 2022 Financial Results and Provides Corporate Update - Vimarsana News

Arbutus Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Published: November 9, 2022

Arbutus Reports Third Quarter 2022 Financial Results and Provides Corporate Update - read this article along with other careers information, tips and advice on BioSpace

Source: biospace.com
Related Topics:
United KingdomUnited StatesLisam CaperelliWilliam CollierN Acetylgalactosamine GalnacWilliamh CollierRoivant Sciences LtdAssembly Biosciences IncWorld Health OrganizationWhile The CompanyArbutus Biopharma Corporation NasdaqUniversity Of British ColumbiaSecurities ExchangeQilu Pharmaceutical Co LtdBiopharma CorporationArbutu PresidentChief ExecutiveAssembly BiosciencesTarget ConferenceOral Capsid InhibitorCash EquivalentsMonths Ended SeptemberShare PurchaseLooking StatementsSecurities Act